Posts by Alexandra S. Bercow, MD
-
Hospital-level Factors Affect Use of Sentinel Lymph Node Biopsy in Early Vulvar Cancer
Alexandra S. Bercow, MD, and colleagues found U.S. patients with early-stage vulvar cancer treated at minority-serving and low-volume hospitals are less likely to undergo sentinel lymph node biopsy. Use of the technique at minority-serving hospitals decreased 67% from 2012 to 2018 despite increasing nationwide.
-
Lymph Node Evaluation Underutilized for Early-stage Vulvar Cancer
Massachusetts General Hospital researchers found in a nationwide study that contrary to guidelines, 34% of eligible patients with early-stage vulvar cancer did not undergo lymph node evaluation. Among patients 80 and older, the figure was 49%, even though withholding lymph node assessment did not improve survival.
-
Specialty Palliative Care Underutilized for Patients with Cervical Cancer
Alexandra S. Bercow, MD and Whitfield B. Growdon, MD, of the Vincent Department of Obstetrics and Gynecology, and colleagues found that even in large institutions with ample resources, 53% of patients who died of cervical cancer were never referred to palliative care services.
-
Review: Prophylactic Surgery for Women at Risk of Hereditary Ovarian or Endometrial Cancer
In women who have certain hereditary cancer mutations, prophylactic surgery can greatly reduce the risk of ovarian and endometrial cancer.
Biography
Alexandra S. Bercow, MD, is a fellow in the Department of Obstetrics and Gynecology at Massachusetts General Hospital.
Obstetrics & Gynecology Care at Mass General
The Mass General Department of Obstetrics & Gynecology offers the highest level of care to women. Our clinical and research team is a leader in advancing treatments for gynecologic cancers, menopause, high-risk obstetrics, infertility and urogynecology.